Intercept Pharmaceuticals Inc (ICPT)

46.52 -1.39  -2.90% NASDAQ Jul 1, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/07/2020 08:30 EDT Misc Intercept Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2020
08/07/2020 Earnings Intercept Pharmaceuticals Inc Second Quarter Earnings in 2020 Release
05/11/2020 08:30 EDT Misc Intercept Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020
05/11/2020 Earnings Intercept Pharmaceuticals Inc First Quarter Earnings Result for 2020
02/25/2020 08:30 EST Misc Intercept Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
02/25/2020 Earnings Intercept Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
02/25/2020 Misc Intercept Pharmaceuticals Inc Annual Report for 2019
11/05/2019 08:30 EST Misc Intercept Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2019
11/05/2019 Earnings Intercept Pharmaceuticals Inc Third Quarter Earnings for 2019 Release
08/07/2019 08:30 EDT Misc Intercept Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.interceptpharma.com
  • Investor Relations URL: http://ir.interceptpharma.com/index.cfm
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 07, 2020
  • Last Earnings Release: May. 11, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.

Top Fund Holders

Symbol Name Weighting
CIG4924 CI Global Health Sciences Corp Cl Y 5.45%
F0000155EU ST Healthcare Innovations 9 F CA 2.97%
F000014EGP ST Healthcare Innovations 8 CA 2.89%
MCC214 Next Edge Bio-Tech Plus F 2.85%
F0000142NF FT Innovative Health Care CA 2.31%
SBIO ALPS Medical Breakthroughs ETF 1.83%
VLIIX Value Line Capital Appreciation Instl 1.48%
LABU Direxion Daily S&P Biotech Bull 3X ETF 0.85%
PSC Principal US Small Cap Mlt Fac Ind ETF 0.65%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.